Pinter, M., Weinmann, A., Wörns, M., Hucke, F., Bota, S., Marquardt, J. U., . . . Sieghart, W. (2017). Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma. United European Gastroenterol J.
Čikaški stil citiranjaPinter, Matthias, et al. "Use of Inhibitors of the Renin–angiotensin System Is Associated With Longer Survival in Patients With Hepatocellular Carcinoma." United European Gastroenterol J 2017.
MLA način citiranjaPinter, Matthias, et al. "Use of Inhibitors of the Renin–angiotensin System Is Associated With Longer Survival in Patients With Hepatocellular Carcinoma." United European Gastroenterol J 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.